Immunic Inc’s recent filing unveils that its Director Rudick Richard Alan acquired Company’s shares for reported $0.1 million on Nov 12 ’24. In the deal valued at $1.15 per share,87,300 shares were bought. As a result of this transaction, Rudick Richard Alan now holds 87,300 shares worth roughly $96030.00000000001.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. SVB Leerink also remained covering IMUX and has decreased its forecast on October 21, 2022 with a “Mkt perform” recommendation from previously “an Outperform” rating.
Price Performance Review of IMUX
On Friday, Immunic Inc [NASDAQ:IMUX] saw its stock fall -0.90% to $1.10. Over the last five days, the stock has gained 3.77%. Immunic Inc shares have fallen nearly -26.67% since the year began. Nevertheless, the stocks have risen 4.76% over the past one year. While a 52-week high of $2.11 was reached on 09/19/24, a 52-week low of $0.97 was recorded on 06/26/24. SMA at 50 days reached $1.4013, while 200 days put it at $1.3347.
Levels Of Support And Resistance For IMUX Stock
The 24-hour chart illustrates a support level at 1.0667, which if violated will result in even more drops to 1.0333. On the upside, there is a resistance level at 1.1267. A further resistance level may holdings at 1.1533. The Relative Strength Index (RSI) on the 14-day chart is 36.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0374, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.63%. Stochastics %K at 28.76% indicates the stock is a holding.
How much short interest is there in Immunic Inc?
A steep rise in short interest was recorded in Immunic Inc stocks on 2024-10-31, growing by 1.82 million shares to a total of 4.5 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 2.68 million shares. There was a rise of 40.39%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 15, 2021 when Aegis Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
